blue cross blue shield glp-1 BCBSM pulling back on coverage BCBS returns to profit after

Considering their mechanism of action, there is a rationale for using GLP-1 agonists in conditions such as dumping syndrome to slow gastric emptying, diarrhoea-dominant IBS, bile acid diarrhoea due to their potentiation of the ileal brake mechanism18 or even short bowel syndrome and high output stomas.19 These are currently not licensed indications nor have any trials been undertaken to date

These drugs are typically prescribed to adults and now teens, who are obese (BMI above 30)

In addition, rising public awareness about weight management and cardiometabolic health is fueling further demand

$279/month , billed as $837 for 12-weeks recurring

the 24 lawsuits brought by brand-name firms against generic competitors are either ongoing (n=14), were settled (n=5), were terminated for procedural reasons (n=2), or were decided in favor of the brand-name firm (n=3)